GlassScriptPhysician profile
Arthur A Altman
NPI 1427012525
$565.37
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $86.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $59.93 | 2019-2020 | |
| Coopersurgical, INC. | $53.99 | 2019 | |
| Daiichi Sankyo INC. | $48.85 | 2019-2020 | |
| Hologic Sales and Service, LLC | $47.95 | 2019 | |
| Amgen INC. | $33.63 | 2019 | |
| Lupin INC. | $28.72 | 2019 | |
| Avion Pharmaceuticals | $28.30 | 2019 | |
| Pfizer INC. | $24.40 | 2019-2020 | |
| Blue Earth Diagnostics | $20.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.48 | 2019 | |
| Therapeuticsmd, INC. | $11.71 | 2020 | |
| Kci USA, INC. | $11.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.